The prognosis of pediatric neuroblastoma (NB) is highly heterogeneous, the long-term survival rate of high-risk or recurrent or refractory NB patients remains less than 50%. Disialoganglioside (GD2) is highly expressed in NB cells, but limited expression in normal tissues. Therefore, GD2 monoclonal antibody (mAb) therapy has become a specific immunotherapy for high-risk and recurrent or refractory NB patients. GD2 mAb binds to GD2 antigen to form immune complex, which plays antitumor effects by inducing antibody-dependent and complement-dependent immune mechanisms. GD2 mAb can significantly improve the survival rate of high-risk and recurrent or refractory NB patients, but attention should be paid to the management of adverse reactions in different groups during treatment. The timing of GD2 mAb combined with chemotherapy, as well as the benefits and risks combined with immune checkpoint inhibitors programmed cell death protein-1/programmed cell death 1 ligand-1, iodine-131-labeled metaiiodo-benzylguanidine or chimeric antigen receptor T cells should be explored. This article reviewed the research progress of GD2 mAb in the treatment of high-risk or recurrent or refractory NB in children in recent years, in order to provide some reference for clinical treatment.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |